APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Histone Deacetylase 1 Industry Growth and Trends Forecast to 2032

19 December 2025110 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 1 Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 1 Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Histone Deacetylase 1 include 4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, Curis, Inc., HitGen LTD, IRBM Science Park SpA, Italfarmaco S.p.A., MEI Pharma, Inc. and Mirati Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Histone Deacetylase 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Histone Deacetylase 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Histone Deacetylase 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Histone Deacetylase 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Histone Deacetylase 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Histone Deacetylase 1 Market by Company

4SC AG

Acetylon Pharmaceuticals, Inc.

Chipscreen Biosciences Ltd

Curis, Inc.

HitGen LTD

IRBM Science Park SpA

Italfarmaco S.p.A.

MEI Pharma, Inc.

Mirati Therapeutics Inc.

Oncolys BioPharma Inc.

Sigma-Tau S.p.A.

Syndax Pharmaceuticals, Inc.

TetraLogic Pharmaceuticals

GlaxoSmithKline Plc

Merck & Co., Inc.

Histone Deacetylase 1 Segment by Type

ST-3595

RCY-1305

HG-3001

CS-3158

ACY-957

Others

Histone Deacetylase 1 Segment by Application

Myelofibrosis

Skin Cancer

Neurology

Alopecia

Endometrial Cancer

Others

Histone Deacetylase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Histone Deacetylase 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Histone Deacetylase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of ST-3595 Table 2. Major Company of RCY-1305 Table 3. Major Company of HG-3001 Table 4. Major Company of CS-3158 Table 5. Major Company of ACY-957 Table 6. Major Company of Others Table 7. Global Histone Deacetylase 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 9. Global Histone Deacetylase 1 Sales Market Share in Volume by Type (2021-2026) Table 10. Global Histone Deacetylase 1 Sales by Type (2021-2026) & (US$ Million) Table 11. Global Histone Deacetylase 1 Sales Market Share in Value by Type (2021-2026) Table 12. Global Histone Deacetylase 1 Price by Type (2021-2026) & (US$/Unit) Table 13. Global Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 14. Global Histone Deacetylase 1 Sales Market Share in Volume by Type (2027-2032) Table 15. Global Histone Deacetylase 1 Sales by Type (2027-2032) & (US$ Million) Table 16. Global Histone Deacetylase 1 Sales Market Share in Value by Type (2027-2032) Table 17. Global Histone Deacetylase 1 Price by Type (2027-2032) & (US$/Unit) Table 18. North America Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 19. North America Histone Deacetylase 1 Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 21. Europe Histone Deacetylase 1 Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Histone Deacetylase 1 Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 25. Latin America Histone Deacetylase 1 Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Histone Deacetylase 1 Sales by Type (2021-2026) & (US$ Million) Table 28. Histone Deacetylase 1 Industry Trends Table 29. Histone Deacetylase 1 Industry Drivers Table 30. Histone Deacetylase 1 Industry Opportunities and Challenges Table 31. Histone Deacetylase 1 Industry Restraints Table 32. Global Histone Deacetylase 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Histone Deacetylase 1 Revenue Market Share by Company (2021-2026) Table 34. Global Histone Deacetylase 1 Sales by Company (2021-2026) & (K Units) Table 35. Global Histone Deacetylase 1 Sales Share by Company (2021-2026) Table 36. Global Histone Deacetylase 1 Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Histone Deacetylase 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Histone Deacetylase 1 Major Company Production Sites and Headquarters Table 39. Global Histone Deacetylase 1 Company, Product Type & Application Table 40. Global Histone Deacetylase 1 Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Histone Deacetylase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Histone Deacetylase 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Histone Deacetylase 1 Sales by Region (2021-2026) & (K Units) Table 45. Global Histone Deacetylase 1 Sales Market Share in Volume by Region (2021-2026) Table 46. Global Histone Deacetylase 1 Sales by Region (2021-2026) & (US$ Million) Table 47. Global Histone Deacetylase 1 Sales Market Share in Value by Region (2021-2026) Table 48. Global Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Histone Deacetylase 1 Sales by Region (2027-2032) & (K Units) Table 50. Global Histone Deacetylase 1 Sales Market Share in Volume by Region (2027-2032) Table 51. Global Histone Deacetylase 1 Sales by Region (2027-2032) & (US$ Million) Table 52. Global Histone Deacetylase 1 Sales Market Share in Value by Region (2027-2032) Table 53. Global Histone Deacetylase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Histone Deacetylase 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 56. Global Histone Deacetylase 1 Sales Market Share in Volume by Application (2021-2026) Table 57. Global Histone Deacetylase 1 Sales by Application (2021-2026) & (US$ Million) Table 58. Global Histone Deacetylase 1 Sales Market Share in Value by Application (2021-2026) Table 59. Global Histone Deacetylase 1 Price by Application (2021-2026) & (US$/Unit) Table 60. Global Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 61. Global Histone Deacetylase 1 Sales Market Share in Volume by Application (2027-2032) Table 62. Global Histone Deacetylase 1 Sales by Application (2027-2032) & (US$ Million) Table 63. Global Histone Deacetylase 1 Sales Market Share in Value by Application (2027-2032) Table 64. Global Histone Deacetylase 1 Price by Application (2027-2032) & (US$/Unit) Table 65. North America Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 66. North America Histone Deacetylase 1 Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 68. Europe Histone Deacetylase 1 Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Histone Deacetylase 1 Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 72. Latin America Histone Deacetylase 1 Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Histone Deacetylase 1 Sales by Application (2021-2026) & (US$ Million) Table 75. 4SC AG Company Information Table 76. 4SC AG Business Overview Table 77. 4SC AG Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. 4SC AG Histone Deacetylase 1 Product Portfolio Table 79. 4SC AG Recent Development Table 80. Acetylon Pharmaceuticals, Inc. Company Information Table 81. Acetylon Pharmaceuticals, Inc. Business Overview Table 82. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 84. Acetylon Pharmaceuticals, Inc. Recent Development Table 85. Chipscreen Biosciences Ltd Company Information Table 86. Chipscreen Biosciences Ltd Business Overview Table 87. Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio Table 89. Chipscreen Biosciences Ltd Recent Development Table 90. Curis, Inc. Company Information Table 91. Curis, Inc. Business Overview Table 92. Curis, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Curis, Inc. Histone Deacetylase 1 Product Portfolio Table 94. Curis, Inc. Recent Development Table 95. HitGen LTD Company Information Table 96. HitGen LTD Business Overview Table 97. HitGen LTD Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. HitGen LTD Histone Deacetylase 1 Product Portfolio Table 99. HitGen LTD Recent Development Table 100. IRBM Science Park SpA Company Information Table 101. IRBM Science Park SpA Business Overview Table 102. IRBM Science Park SpA Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio Table 104. IRBM Science Park SpA Recent Development Table 105. Italfarmaco S.p.A. Company Information Table 106. Italfarmaco S.p.A. Business Overview Table 107. Italfarmaco S.p.A. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio Table 109. Italfarmaco S.p.A. Recent Development Table 110. MEI Pharma, Inc. Company Information Table 111. MEI Pharma, Inc. Business Overview Table 112. MEI Pharma, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio Table 114. MEI Pharma, Inc. Recent Development Table 115. Mirati Therapeutics Inc. Company Information Table 116. Mirati Therapeutics Inc. Business Overview Table 117. Mirati Therapeutics Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio Table 119. Mirati Therapeutics Inc. Recent Development Table 120. Oncolys BioPharma Inc. Company Information Table 121. Oncolys BioPharma Inc. Business Overview Table 122. Oncolys BioPharma Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio Table 124. Oncolys BioPharma Inc. Recent Development Table 125. Sigma-Tau S.p.A. Company Information Table 126. Sigma-Tau S.p.A. Business Overview Table 127. Sigma-Tau S.p.A. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio Table 129. Sigma-Tau S.p.A. Recent Development Table 130. Syndax Pharmaceuticals, Inc. Company Information Table 131. Syndax Pharmaceuticals, Inc. Business Overview Table 132. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 134. Syndax Pharmaceuticals, Inc. Recent Development Table 135. TetraLogic Pharmaceuticals Company Information Table 136. TetraLogic Pharmaceuticals Business Overview Table 137. TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio Table 139. TetraLogic Pharmaceuticals Recent Development Table 140. GlaxoSmithKline Plc Company Information Table 141. GlaxoSmithKline Plc Business Overview Table 142. GlaxoSmithKline Plc Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio Table 144. GlaxoSmithKline Plc Recent Development Table 145. Merck & Co., Inc. Company Information Table 146. Merck & Co., Inc. Business Overview Table 147. Merck & Co., Inc. Histone Deacetylase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio Table 149. Merck & Co., Inc. Recent Development Table 150. North America Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 151. North America Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 152. North America Histone Deacetylase 1 Sales Market Share by Country (2021-2026) Table 153. North America Histone Deacetylase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 154. North America Histone Deacetylase 1 Sales Market Share Forecast by Country (2027-2032) Table 155. North America Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. North America Histone Deacetylase 1 Market Size by Country (2021-2026) & (US$ Million) Table 157. North America Histone Deacetylase 1 Market Share by Country (2021-2026) Table 158. North America Histone Deacetylase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. North America Histone Deacetylase 1 Market Share Forecast by Country (2027-2032) Table 160. Europe Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 161. Europe Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 162. Europe Histone Deacetylase 1 Sales Market Share by Country (2021-2026) Table 163. Europe Histone Deacetylase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 164. Europe Histone Deacetylase 1 Sales Market Share Forecast by Country (2027-2032) Table 165. Europe Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Europe Histone Deacetylase 1 Market Size by Country (2021-2026) & (US$ Million) Table 167. Europe Histone Deacetylase 1 Market Share by Country (2021-2026) Table 168. Europe Histone Deacetylase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Europe Histone Deacetylase 1 Market Share Forecast by Country (2027-2032) Table 170. Asia-Pacific Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 171. Asia-Pacific Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 172. Asia-Pacific Histone Deacetylase 1 Sales Market Share by Country (2021-2026) Table 173. Asia-Pacific Histone Deacetylase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 174. Asia-Pacific Histone Deacetylase 1 Sales Market Share Forecast by Country (2027-2032) Table 175. Asia-Pacific Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Asia-Pacific Histone Deacetylase 1 Market Size by Country (2021-2026) & (US$ Million) Table 177. Asia-Pacific Histone Deacetylase 1 Market Share by Country (2021-2026) Table 178. Asia-Pacific Histone Deacetylase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Asia-Pacific Histone Deacetylase 1 Market Share Forecast by Country (2027-2032) Table 180. Latin America Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 181. Latin America Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 182. Latin America Histone Deacetylase 1 Sales Market Share by Country (2021-2026) Table 183. Latin America Histone Deacetylase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 184. Latin America Histone Deacetylase 1 Sales Market Share Forecast by Country (2027-2032) Table 185. Latin America Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 186. Latin America Histone Deacetylase 1 Market Size by Country (2021-2026) & (US$ Million) Table 187. Latin America Histone Deacetylase 1 Market Share by Country (2021-2026) Table 188. Latin America Histone Deacetylase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 189. Latin America Histone Deacetylase 1 Market Share Forecast by Country (2027-2032) Table 190. Middle East and Africa Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 191. Middle East and Africa Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 192. Middle East and Africa Histone Deacetylase 1 Sales Market Share by Country (2021-2026) Table 193. Middle East and Africa Histone Deacetylase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 194. Middle East and Africa Histone Deacetylase 1 Sales Market Share Forecast by Country (2027-2032) Table 195. Middle East and Africa Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 196. Middle East and Africa Histone Deacetylase 1 Market Size by Country (2021-2026) & (US$ Million) Table 197. Middle East and Africa Histone Deacetylase 1 Market Share by Country (2021-2026) Table 198. Middle East and Africa Histone Deacetylase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 199. Middle East and Africa Histone Deacetylase 1 Market Share Forecast by Country (2027-2032) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Histone Deacetylase 1 Distributors List Table 203. Histone Deacetylase 1 Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Histone Deacetylase 1 Image Figure 2. Global Histone Deacetylase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Histone Deacetylase 1 Sales (2021-2032) & (K Units) Figure 5. ST-3595 Image Figure 6. Global ST-3595 Sales YoY Growth (2021-2032) & (K Units) Figure 7. RCY-1305 Image Figure 8. Global RCY-1305 Sales YoY Growth (2021-2032) & (K Units) Figure 9. HG-3001 Image Figure 10. Global HG-3001 Sales YoY Growth (2021-2032) & (K Units) Figure 11. CS-3158 Image Figure 12. Global CS-3158 Sales YoY Growth (2021-2032) & (K Units) Figure 13. ACY-957 Image Figure 14. Global ACY-957 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Histone Deacetylase 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Histone Deacetylase 1 Market Share by Type 2025 VS 2032 Figure 19. North America Histone Deacetylase 1 Sales Market Share in Volume by Type in 2025 Figure 20. North America Histone Deacetylase 1 Sales Market Share in Value by Type in 2025 Figure 21. Europe Histone Deacetylase 1 Sales Market Share in Volume by Type in 2025 Figure 22. Europe Histone Deacetylase 1 Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Histone Deacetylase 1 Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Histone Deacetylase 1 Sales Market Share in Value by Type in 2025 Figure 25. Latin America Histone Deacetylase 1 Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Histone Deacetylase 1 Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Histone Deacetylase 1 Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Histone Deacetylase 1 Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Histone Deacetylase 1 Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Myelofibrosis Image Figure 32. Global Myelofibrosis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Skin Cancer Image Figure 34. Global Skin Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 35. Neurology Image Figure 36. Global Neurology Sales YoY Growth (2021-2032) & (K Units) Figure 37. Alopecia Image Figure 38. Global Alopecia Sales YoY Growth (2021-2032) & (K Units) Figure 39. Endometrial Cancer Image Figure 40. Global Endometrial Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 41. Others Image Figure 42. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 43. Global Histone Deacetylase 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global Histone Deacetylase 1 Market Share by Application 2025 VS 2032 Figure 45. North America Histone Deacetylase 1 Sales Market Share in Volume by Application in 2025 Figure 46. North America Histone Deacetylase 1 Sales Market Share in Value by Application in 2025 Figure 47. Europe Histone Deacetylase 1 Sales Market Share in Volume by Application in 2025 Figure 48. Europe Histone Deacetylase 1 Sales Market Share in Value by Application in 2025 Figure 49. Asia-Pacific Histone Deacetylase 1 Sales Market Share in Volume by Application in 2025 Figure 50. Asia-Pacific Histone Deacetylase 1 Sales Market Share in Value by Application in 2025 Figure 51. Latin America Histone Deacetylase 1 Sales Market Share in Volume by Application in 2025 Figure 52. Latin America Histone Deacetylase 1 Sales Market Share in Value by Application in 2025 Figure 53. Middle East and Africa Histone Deacetylase 1 Sales Market Share in Volume by Application in 2025 Figure 54. Middle East and Africa Histone Deacetylase 1 Sales Market Share in Value by Application in 2025 Figure 55. North America Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. North America Histone Deacetylase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. North America Histone Deacetylase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. North America Histone Deacetylase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Europe Histone Deacetylase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Histone Deacetylase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Europe Histone Deacetylase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Asia-Pacific Histone Deacetylase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Histone Deacetylase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Asia-Pacific Histone Deacetylase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Latin America Histone Deacetylase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Latin America Histone Deacetylase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Latin America Histone Deacetylase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Histone Deacetylase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 72. Middle East and Africa Histone Deacetylase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 73. Middle East and Africa Histone Deacetylase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 74. Middle East and Africa Histone Deacetylase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 75. Histone Deacetylase 1 Value Chain Figure 76. Key Raw Materials Price Figure 77. Manufacturing Cost Structure Figure 78. Histone Deacetylase 1 Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Years Considered Figure 82. Research Process Figure 83. Key Executives Interviewed

Scope & coverage.

Types
  • ST-3595
  • RCY-1305
  • HG-3001
  • CS-3158
  • ACY-957
  • Others
Applications
  • Myelofibrosis
  • Skin Cancer
  • Neurology
  • Alopecia
  • Endometrial Cancer
  • Others
Companies covered
  • 4SC AG
  • Acetylon Pharmaceuticals, Inc.
  • Chipscreen Biosciences Ltd
  • Curis, Inc.
  • HitGen LTD
  • IRBM Science Park SpA
  • Italfarmaco S.p.A.
  • MEI Pharma, Inc.
  • Mirati Therapeutics Inc.
  • Oncolys BioPharma Inc.
  • Sigma-Tau S.p.A.
  • Syndax Pharmaceuticals, Inc.
  • TetraLogic Pharmaceuticals
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Histone Deacetylase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Histone Deacetylase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Histone Deacetylase 1 Market by Type
  6. 1.3.1 ST-3595
  7. 1.3.2 RCY-1305
  8. 1.3.3 HG-3001
  9. 1.3.4 CS-3158
  10. 1.3.5 ACY-957
  11. 1.3.6 Others
  12. 1.4 Global Histone Deacetylase 1 Market Size by Type
  13. 1.4.1 Global Histone Deacetylase 1 Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Histone Deacetylase 1 Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Histone Deacetylase 1 Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Histone Deacetylase 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Histone Deacetylase 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Histone Deacetylase 1 Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Histone Deacetylase 1 Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Histone Deacetylase 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Histone Deacetylase 1 Industry Trends
  2. 2.2 Histone Deacetylase 1 Industry Drivers
  3. 2.3 Histone Deacetylase 1 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Histone Deacetylase 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Histone Deacetylase 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Histone Deacetylase 1 Price (2021-2026)
  4. 3.4 Global Histone Deacetylase 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Histone Deacetylase 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Histone Deacetylase 1 Company, Product Type & Application
  7. 3.7 Global Histone Deacetylase 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Histone Deacetylase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Histone Deacetylase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Histone Deacetylase 1 Tier 1, Tier 2, and Tier 3
4 Histone Deacetylase 1 Regional Status and Outlook
  1. 4.1 Global Histone Deacetylase 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Histone Deacetylase 1 Historic Market Size by Region
  3. 4.2.1 Global Histone Deacetylase 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Histone Deacetylase 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Histone Deacetylase 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Histone Deacetylase 1 Forecasted Market Size by Region
  7. 4.3.1 Global Histone Deacetylase 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Histone Deacetylase 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Histone Deacetylase 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Histone Deacetylase 1 by Application
  1. 5.1 Histone Deacetylase 1 Market by Application
  2. 5.1.1 Myelofibrosis
  3. 5.1.2 Skin Cancer
  4. 5.1.3 Neurology
  5. 5.1.4 Alopecia
  6. 5.1.5 Endometrial Cancer
  7. 5.1.6 Others
  8. 5.2 Global Histone Deacetylase 1 Market Size by Application
  9. 5.2.1 Global Histone Deacetylase 1 Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Histone Deacetylase 1 Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Histone Deacetylase 1 Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Histone Deacetylase 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Histone Deacetylase 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Histone Deacetylase 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Histone Deacetylase 1 Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Histone Deacetylase 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 4SC AG
  2. 6.1.1 4SC AG Company Information
  3. 6.1.2 4SC AG Business Overview
  4. 6.1.3 4SC AG Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 4SC AG Histone Deacetylase 1 Product Portfolio
  6. 6.1.5 4SC AG Recent Developments
  7. 6.2 Acetylon Pharmaceuticals, Inc.
  8. 6.2.1 Acetylon Pharmaceuticals, Inc. Company Information
  9. 6.2.2 Acetylon Pharmaceuticals, Inc. Business Overview
  10. 6.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  12. 6.2.5 Acetylon Pharmaceuticals, Inc. Recent Developments
  13. 6.3 Chipscreen Biosciences Ltd
  14. 6.3.1 Chipscreen Biosciences Ltd Company Information
  15. 6.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 6.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio
  18. 6.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 6.4 Curis, Inc.
  20. 6.4.1 Curis, Inc. Company Information
  21. 6.4.2 Curis, Inc. Business Overview
  22. 6.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Curis, Inc. Histone Deacetylase 1 Product Portfolio
  24. 6.4.5 Curis, Inc. Recent Developments
  25. 6.5 HitGen LTD
  26. 6.5.1 HitGen LTD Company Information
  27. 6.5.2 HitGen LTD Business Overview
  28. 6.5.3 HitGen LTD Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HitGen LTD Histone Deacetylase 1 Product Portfolio
  30. 6.5.5 HitGen LTD Recent Developments
  31. 6.6 IRBM Science Park SpA
  32. 6.6.1 IRBM Science Park SpA Company Information
  33. 6.6.2 IRBM Science Park SpA Business Overview
  34. 6.6.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio
  36. 6.6.5 IRBM Science Park SpA Recent Developments
  37. 6.7 Italfarmaco S.p.A.
  38. 6.7.1 Italfarmaco S.p.A. Company Information
  39. 6.7.2 Italfarmaco S.p.A. Business Overview
  40. 6.7.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio
  42. 6.7.5 Italfarmaco S.p.A. Recent Developments
  43. 6.8 MEI Pharma, Inc.
  44. 6.8.1 MEI Pharma, Inc. Company Information
  45. 6.8.2 MEI Pharma, Inc. Business Overview
  46. 6.8.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio
  48. 6.8.5 MEI Pharma, Inc. Recent Developments
  49. 6.9 Mirati Therapeutics Inc.
  50. 6.9.1 Mirati Therapeutics Inc. Company Information
  51. 6.9.2 Mirati Therapeutics Inc. Business Overview
  52. 6.9.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio
  54. 6.9.5 Mirati Therapeutics Inc. Recent Developments
  55. 6.10 Oncolys BioPharma Inc.
  56. 6.10.1 Oncolys BioPharma Inc. Company Information
  57. 6.10.2 Oncolys BioPharma Inc. Business Overview
  58. 6.10.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio
  60. 6.10.5 Oncolys BioPharma Inc. Recent Developments
  61. 6.11 Sigma-Tau S.p.A.
  62. 6.11.1 Sigma-Tau S.p.A. Company Information
  63. 6.11.2 Sigma-Tau S.p.A. Business Overview
  64. 6.11.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio
  66. 6.11.5 Sigma-Tau S.p.A. Recent Developments
  67. 6.12 Syndax Pharmaceuticals, Inc.
  68. 6.12.1 Syndax Pharmaceuticals, Inc. Company Information
  69. 6.12.2 Syndax Pharmaceuticals, Inc. Business Overview
  70. 6.12.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  72. 6.12.5 Syndax Pharmaceuticals, Inc. Recent Developments
  73. 6.13 TetraLogic Pharmaceuticals
  74. 6.13.1 TetraLogic Pharmaceuticals Company Information
  75. 6.13.2 TetraLogic Pharmaceuticals Business Overview
  76. 6.13.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio
  78. 6.13.5 TetraLogic Pharmaceuticals Recent Developments
  79. 6.14 GlaxoSmithKline Plc
  80. 6.14.1 GlaxoSmithKline Plc Company Information
  81. 6.14.2 GlaxoSmithKline Plc Business Overview
  82. 6.14.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio
  84. 6.14.5 GlaxoSmithKline Plc Recent Developments
  85. 6.15 Merck & Co., Inc.
  86. 6.15.1 Merck & Co., Inc. Company Information
  87. 6.15.2 Merck & Co., Inc. Business Overview
  88. 6.15.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio
  90. 6.15.5 Merck & Co., Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Histone Deacetylase 1 Sales by Country
  2. 7.1.1 North America Histone Deacetylase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Histone Deacetylase 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Histone Deacetylase 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Histone Deacetylase 1 Market Size by Country
  6. 7.2.1 North America Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Histone Deacetylase 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Histone Deacetylase 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Histone Deacetylase 1 Sales by Country
  2. 8.1.1 Europe Histone Deacetylase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Histone Deacetylase 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Histone Deacetylase 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Histone Deacetylase 1 Market Size by Country
  6. 8.2.1 Europe Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Histone Deacetylase 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Histone Deacetylase 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Histone Deacetylase 1 Sales by Country
  2. 9.1.1 Asia-Pacific Histone Deacetylase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Histone Deacetylase 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Histone Deacetylase 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Histone Deacetylase 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Histone Deacetylase 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Histone Deacetylase 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Histone Deacetylase 1 Sales by Country
  2. 10.1.1 South America Histone Deacetylase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Histone Deacetylase 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Histone Deacetylase 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Histone Deacetylase 1 Market Size by Country
  6. 10.2.1 South America Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Histone Deacetylase 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Histone Deacetylase 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Histone Deacetylase 1 Sales by Country
  2. 11.1.1 Middle East and Africa Histone Deacetylase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Histone Deacetylase 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Histone Deacetylase 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Histone Deacetylase 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Histone Deacetylase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Histone Deacetylase 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Histone Deacetylase 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Histone Deacetylase 1 Value Chain Analysis
  2. 12.1.1 Histone Deacetylase 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Histone Deacetylase 1 Production Mode & Process
  7. 12.2 Histone Deacetylase 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Histone Deacetylase 1 Distributors
  10. 12.2.3 Histone Deacetylase 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst